Impact of Pharmaceutical Interviews on the Medication Adherence of Epileptic Patients
Key facts
- Who runs it
- University Hospital, Lille
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 51 people enrolled
- Started
- 1 Oct 2021
- Ended
- 1 Oct 2024
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Pharmacist intervention
- Standard of care
- Record updated
- 29 May 2025
- Why it stopped
- Sponsor's decesion, no inclusion since august 2022
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Epileptic patients seeing a neurologist in the neurophysiology clinic with a regular follow-up by the Lille University Hospital reference center
- Adult over 18 years old
- Living at home
- Socially insured patient
- In the case of cognitive problems, the presence of a reliable caregiver managing the medications
Who cannot take part
- Patient who has participated in a therapeutic education program (TEP) about his epilepsy within the previous two years
- Dementia
- Inpatients
- Patient under curatorship, guardianship and/or institutionalized
- Administrative reasons: impossibility to receive informed information, impossibility to participate in the entire study, lack of coverage by the social security system, refusal to sign the consent form
- Switching to home care by a registered nurse for treatment management
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Many studies have reported a disparity in medication adherence among epileptic patients. In this population, Medication Possession Ratio (MPR) is an index of medication adherence. MPR is defined as the ratio of the number of days of treatment delivered to the number of days in the period of interest.
Read full original descriptionShow less
No-adherents patients are defined by a MPR of less than 80% , in whom an increase in seizures and the rate of hospitalization can be observed. A pharmacist-led intervention and medication information to epileptic patients could improve patient medication adherence to antiepileptic drugs, and possibly decrease the frequency of seizures, hospitalizations and the health costs generated by these hospitalizations. This intervention could also improve patient knowledge about their medications.
The aim of this study is to evaluate the effectiveness of a pharmacist-led intervention on medication adherence of epileptic patients with the MPR. Secondary objectives include the comparison of medication adherence with health insurance score, the evaluation of patients knowledges about their medications, community pharmacists' satisfaction about community hospital network, the comparison of the seizure free patient rate and the comparison of the rate of patient in whom seizure have decreased by 50%
The 2 groups in the trial
- Pharmacist-led interventionTreatment being tested
Treatment: Pharmacist intervention
- Standard of careSham treatment, for comparison
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Study of the Impact of Pharmaceutical Interventions on the Medication Adherence of Epileptic Patients and Their Medication Knowledge
- Record updated
- 29 May 2025